Home » Authors » Anette Breindl

Articles by Anette Breindl

Looking Upstream For New Cancer Metastasis Insights

Nov. 2, 2004

By Anette Breindl

Effects Impressive, Mechanism Elusive For Endocannabinoids

Nov. 1, 2004

By Anette Breindl

Effects Impressive, Mechanism Elusive For Endocannabinoids

Nov. 1, 2004

By Anette Breindl

Although Vioxx Troubled, Cox-2 Area Still Of Interest

Oct. 28, 2004

By Anette Breindl

Although Vioxx Troubled, Cox-2 Area Still Of Interest

Oct. 28, 2004

By Anette Breindl

Retrotransposons: 'Junk' DNA? No, Instead Alternate Promoters

Oct. 26, 2004

By Anette Breindl

Combination Agent Showing Antitumor Effects Flying Solo

Oct. 25, 2004

By Anette Breindl

Combination Agent Showing Antitumor Effects Flying Solo

Oct. 25, 2004

By Anette Breindl

Adenosine Receptors Linked To Stroke-Induced Brain Damage

Oct. 20, 2004

By Anette Breindl

Adenosine Receptors Linked To Stroke-Induced Brain Damage

Oct. 20, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...